• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HEARTWARE, INC. HEARTWARE VENTRICULAR ASSIST SYSTEM - PUMP/DRIVELINE; VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HEARTWARE, INC. HEARTWARE VENTRICULAR ASSIST SYSTEM - PUMP/DRIVELINE; VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 1103
Device Problems Obstruction of Flow (2423); Malposition of Device (2616); Pumping Problem (3016)
Patient Problems Aortic Valve Insufficiency/ Regurgitation (4450); Mitral Valve Insufficiency/ Regurgitation (4451)
Event Date 01/19/2019
Event Type  Injury  
Event Description
It was reported the ventricular assist device (vad) patient was admitted to the hospital for suspicion of outflow graft (ofg) obstruction, as the patient presented with low flow alarms.The low flows did not respond to speed increases.An echocardiogram, (echo) showed a new aortic valve opening and significant mitral regurgitation (mir) with an unclear amount of flow going through the left ventricular assist device (lvad) cannula, which is admittedly not well-positioned as it appears now directed towards the septum.No suction or hemolysis was noted, no concern for thrombus as lactate dehydrogenase (ldh) and power were within range.It was noted that the patient had an 80-pound weight loss.It was also reported that there was suspicion of some kind of change in the patient ofg positioning, and kinking or there was obstruction of or around the ofg.It was also reported that the patient underwent intervention to the ofg with three covered stents and a reduction of the ofg gradient.The patient had immediate improvement in the flow at a much slower speed post-stent deployment.The vad was set at 2500rpm with a flow of 4-4.5 liters per minute (lpm), and the patient was continued on a low dose of blood pressure medication.The vad and outflow graft remain in use.No further patient complications have been reported as a result of this event.
 
Manufacturer Narrative
Investigation of this event is pending and a supplemental report will be sent upon its completion.Additional products: d1: heartware ventricular assist system ¿ outflow graft d4: model#: 1125 / catalog#: 1125 / expiration date: dd-mmm-yyyy / lot#: 1001873735.D9: no.H3: no.H4: mfg date: dd-mmm-yyyy h5: yes.H6: the codes present in section h6 correspond to components/products that comprise the reported event.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTWARE VENTRICULAR ASSIST SYSTEM - PUMP/DRIVELINE
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
HEARTWARE, INC.
14400 nw 60th ave
miami lakes FL 33014
Manufacturer (Section G)
HEARTWARE, INC.
14400 nw 60th ave
miami lakes FL 33014
Manufacturer Contact
paula bixby
8200 coral sea st ne
mounds view, MN 55112
7635055378
MDR Report Key18881544
MDR Text Key337414351
Report Number3007042319-2024-01200
Device Sequence Number1
Product Code DSQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/11/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number1103
Device Catalogue Number1103
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/05/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
693565 LEAD, CD1231-40 ICD
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age31 YR
Patient SexFemale
Patient Weight87 KG
-
-